437 related articles for article (PubMed ID: 33924142)
1. Circulating miRNAs Act as Diagnostic Biomarkers for Bladder Cancer in Urine.
Lin JT; Tsai KW
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33924142
[TBL] [Abstract][Full Text] [Related]
2. MicroRNAs in tumor samples and urinary extracellular vesicles as a putative diagnostic tool for muscle-invasive bladder cancer.
Baumgart S; Meschkat P; Edelmann P; Heinzelmann J; Pryalukhin A; Bohle R; Heinzelbecker J; Stöckle M; Junker K
J Cancer Res Clin Oncol; 2019 Nov; 145(11):2725-2736. PubMed ID: 31552489
[TBL] [Abstract][Full Text] [Related]
3. Genome-wide identification of urinary cell-free microRNAs for non-invasive detection of bladder cancer.
Juracek J; Peltanova B; Dolezel J; Fedorko M; Pacik D; Radova L; Vesela P; Svoboda M; Slaby O; Stanik M
J Cell Mol Med; 2018 Mar; 22(3):2033-2038. PubMed ID: 29363887
[TBL] [Abstract][Full Text] [Related]
4. Connecting the dots between different networks: miRNAs associated with bladder cancer risk and progression.
Braicu C; Buiga R; Cojocneanu R; Buse M; Raduly L; Pop LA; Chira S; Budisan L; Jurj A; Ciocan C; Magdo L; Irimie A; Dobrota F; Petrut B; Berindan-Neagoe I
J Exp Clin Cancer Res; 2019 Oct; 38(1):433. PubMed ID: 31665050
[TBL] [Abstract][Full Text] [Related]
5. miR-21-5p, miR-141-3p, and miR-205-5p levels in urine-promising biomarkers for the identification of prostate and bladder cancer.
Ghorbanmehr N; Gharbi S; Korsching E; Tavallaei M; Einollahi B; Mowla SJ
Prostate; 2019 Jan; 79(1):88-95. PubMed ID: 30194772
[TBL] [Abstract][Full Text] [Related]
6. Identification of circulating miRNAs as novel prognostic biomarkers for bladder cancer.
Lin GB; Zhang CM; Chen XY; Wang JW; Chen S; Tang SY; Yu TQ
Math Biosci Eng; 2019 Nov; 17(1):834-844. PubMed ID: 31731380
[TBL] [Abstract][Full Text] [Related]
7. Expression Level of Urinary MicroRNA-146a-5p Is Increased in Patients With Bladder Cancer and Decreased in Those After Transurethral Resection.
Sasaki H; Yoshiike M; Nozawa S; Usuba W; Katsuoka Y; Aida K; Kitajima K; Kudo H; Hoshikawa M; Yoshioka Y; Kosaka N; Ochiya T; Chikaraishi T
Clin Genitourin Cancer; 2016 Oct; 14(5):e493-e499. PubMed ID: 27157639
[TBL] [Abstract][Full Text] [Related]
8. Identification and validation of reference genes for the detection of serum microRNAs by reverse transcription-quantitative polymerase chain reaction in patients with bladder cancer.
Wang L; Liu Y; Du L; Li J; Jiang X; Zheng G; Qu A; Wang H; Wang L; Zhang X; Liu H; Pan H; Yang Y; Wang C
Mol Med Rep; 2015 Jul; 12(1):615-22. PubMed ID: 25738263
[TBL] [Abstract][Full Text] [Related]
9. Urinary Exosomal miRNAs as biomarkers of bladder Cancer and experimental verification of mechanism of miR-93-5p in bladder Cancer.
Lin H; Shi X; Li H; Hui J; Liu R; Chen Z; Lu Y; Tan W
BMC Cancer; 2021 Dec; 21(1):1293. PubMed ID: 34861847
[TBL] [Abstract][Full Text] [Related]
10. A two-miRNA signature of upregulated miR-185-5p and miR-362-5p as a blood biomarker for breast cancer.
Zhang K; Wang YY; Xu Y; Zhang L; Zhu J; Si PC; Wang YW; Ma R
Pathol Res Pract; 2021 Jun; 222():153458. PubMed ID: 33962174
[TBL] [Abstract][Full Text] [Related]
11. Identification of microRNA biomarkers in the blood of breast cancer patients based on microRNA profiling.
Zhang K; Wang YW; Wang YY; Song Y; Zhu J; Si PC; Ma R
Gene; 2017 Jul; 619():10-20. PubMed ID: 28359916
[TBL] [Abstract][Full Text] [Related]
12. Urinary exosomal microRNA-96-5p and microRNA-183-5p expression as potential biomarkers of bladder cancer.
El-Shal AS; Shalaby SM; Abouhashem SE; Elbary EHA; Azazy S; Rashad NM; Sarhan W
Mol Biol Rep; 2021 May; 48(5):4361-4371. PubMed ID: 34085193
[TBL] [Abstract][Full Text] [Related]
13. Salivary microRNA miR-let-7a-5p and miR-3928 could be used as potential diagnostic bio-markers for head and neck squamous cell carcinoma.
Fadhil RS; Wei MQ; Nikolarakos D; Good D; Nair RG
PLoS One; 2020; 15(3):e0221779. PubMed ID: 32208417
[TBL] [Abstract][Full Text] [Related]
14. Identification of a 7-microRNA signature in plasma as promising biomarker for nasopharyngeal carcinoma detection.
Zhang H; Zou X; Wu L; Zhang S; Wang T; Liu P; Zhu W; Zhu J
Cancer Med; 2020 Feb; 9(3):1230-1241. PubMed ID: 31856390
[TBL] [Abstract][Full Text] [Related]
15. Plasma Circulating Mirnas Profiling for Identification of Potential Breast Cancer Early Detection Biomarkers.
Jusoh AR; Mohan SV; Lu Ping T; Tengku Din TADAAB; Haron J; Romli RC; Jaafar H; Nafi SN; Tuan Salwani TI; Yahya MM
Asian Pac J Cancer Prev; 2021 May; 22(5):1375-1381. PubMed ID: 34048164
[TBL] [Abstract][Full Text] [Related]
16. Cell-free microRNA expression signatures in urine serve as novel noninvasive biomarkers for diagnosis and recurrence prediction of bladder cancer.
Du L; Jiang X; Duan W; Wang R; Wang L; Zheng G; Yan K; Wang L; Li J; Zhang X; Pan H; Yang Y; Wang C
Oncotarget; 2017 Jun; 8(25):40832-40842. PubMed ID: 28388561
[TBL] [Abstract][Full Text] [Related]
17. Expression of miRNAs involved in angiogenesis, tumor cell proliferation, tumor suppressor inhibition, epithelial-mesenchymal transition and activation of metastasis in bladder cancer.
Zaravinos A; Radojicic J; Lambrou GI; Volanis D; Delakas D; Stathopoulos EN; Spandidos DA
J Urol; 2012 Aug; 188(2):615-23. PubMed ID: 22704449
[TBL] [Abstract][Full Text] [Related]
18. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.
Zhang Y; Sui J; Shen X; Li C; Yao W; Hong W; Peng H; Pu Y; Yin L; Liang G
Oncol Rep; 2017 Jun; 37(6):3543-3553. PubMed ID: 28498428
[TBL] [Abstract][Full Text] [Related]
19. Serum miR-122-5p and miR-206 expression: non-invasive prognostic biomarkers for renal cell carcinoma.
Heinemann FG; Tolkach Y; Deng M; Schmidt D; Perner S; Kristiansen G; Müller SC; Ellinger J
Clin Epigenetics; 2018; 10():11. PubMed ID: 29410711
[TBL] [Abstract][Full Text] [Related]
20. Aberrant expression of microRNAs in bladder cancer.
Yoshino H; Seki N; Itesako T; Chiyomaru T; Nakagawa M; Enokida H
Nat Rev Urol; 2013 Jul; 10(7):396-404. PubMed ID: 23712207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]